Thong Yuen Poon
Director/Board Member at Zicom MedTacc Pte Ltd.
Profile
Thong Yuen Poon currently works at Zicom MedTacc Pte Ltd., as Director from 2018.
Dr. Poon also formerly worked at Histoindex Pte Ltd., as Chief Executive Officer & Director, Sotera Wireless, Inc., as Director, FORMA Therapeutics, Inc., as Director, Ivantis, Inc., as Director, Amaranth Medical, Inc., as Director, Artisan Pharma, Inc., as Director, Inviragen, Inc., as Director, Amaranth Medical Pte Ltd., as Director, MiRXES Pte Ltd., as Director, Hyphens Pharma International Ltd., as Independent Non-Executive Director from 2018 to 2020, EDB Investments Pte Ltd., as Vice President from 2008 to 2016, and Bio*One Capital Pte Ltd., as Manager-Investments.
Dr. Poon received his undergraduate degree in 2000 from National University of Singapore and doctorate degree in 2004 from National University of Singapore.
Thong Yuen Poon active positions
Companies | Position | Start |
---|---|---|
Zicom MedTacc Pte Ltd.
Zicom MedTacc Pte Ltd. Engineering & ConstructionIndustrial Services Zicom MedTacc Pte Ltd. provides engineering services. It operates as an equipment manufacturer and niche engineering service provider. The firm specializes in mechanical, hydraulics, precision, and instrumentation engineering. The company is headquartered in Singapore. | Director/Board Member | 2018-05-31 |
Former positions of Thong Yuen Poon
Companies | Position | End |
---|---|---|
HYPHENS PHARMA INTERNATIONAL LIMITED | Director/Board Member | 2020-05-07 |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Private Equity Investor | 2016-08-30 |
Histoindex Pte Ltd.
Histoindex Pte Ltd. Medical SpecialtiesHealth Technology Histoindex Pte Ltd. is a medtech/healthcare company based in Singapore, Singapore. The stain-free AI platform is currently involved in multiple FDA clinical trials for nonalcoholic steatohepatitis (NASH) and has benefitted more than 150 research and academic institutes, CROs, and biopharma companies worldwide in drug discovery and development efforts for fibrotic diseases and cancers. Founded in 2010, the Singaporean company specializes in its proprietary integrated stain-free AI digital pathology platform that accurately quantifies histological features and fine measurements critical for the evaluation of therapeutic efficacy in clinical trials. The company was founded by Gideon Ho, Chi-Shang Tai, and Gideon Ho has been the CEO since incorporation. | Chief Executive Officer | - |
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | Director/Board Member | - |
Sotera Wireless, Inc.
Sotera Wireless, Inc. Medical SpecialtiesHealth Technology Sotera Wireless Inc. develops medical devices. It develops, markets, and sells a vital signs monitoring solution. It offers ViSi Mobile System, a platform for vital signs monitoring solution that is designed to keep clinicians connected to their patients. The company was founded in 2004 and is headquartered in San Diego, CA. | Director/Board Member | - |
Training of Thong Yuen Poon
National University of Singapore | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HYPHENS PHARMA INTERNATIONAL LIMITED | Health Technology |
Private companies | 12 |
---|---|
Sotera Wireless, Inc.
Sotera Wireless, Inc. Medical SpecialtiesHealth Technology Sotera Wireless Inc. develops medical devices. It develops, markets, and sells a vital signs monitoring solution. It offers ViSi Mobile System, a platform for vital signs monitoring solution that is designed to keep clinicians connected to their patients. The company was founded in 2004 and is headquartered in San Diego, CA. | Health Technology |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Health Technology |
Ivantis, Inc.
Ivantis, Inc. Medical SpecialtiesHealth Technology Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA. | Health Technology |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Finance |
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
Amaranth Medical, Inc.
Amaranth Medical, Inc. Pharmaceuticals: MajorHealth Technology Amaranth Medical, Inc. develops and manufactures a technology platform for fully bioresorbable scaffolds. It operates as a holding company that engages in the development and manufacture of technology platform for fully bioresorbable scaffolds. Its proprietary bioresorbable technology platform holds great potential for both vascular and nonvascular applications. The company was founded by Freddy Yin Chiang Boey and Subbu S. Venkatraman in 2005 and is headquartered in Mountain View, CA. | Health Technology |
Artisan Pharma, Inc.
Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Artisan Pharma, Inc. provides critical-care and hospital-based therapeutics to patients. The firm focuses on the clinical development of drugs in the field of critical care therapeutics throughout the world. The company was founded by Kazuhisa Tsuruta in 2006 and is headquartered in Waltham, MA. | Health Services |
Inviragen, Inc.
Inviragen, Inc. BiotechnologyHealth Technology Inviragen, Inc. developed life-saving vaccine to protect against infectious diseases worldwide. The company was founded by Dan T. Stinchcomb and Jorge Osorio in November 2003 and was headquartered in Fort Collins, CO. | Health Technology |
Zicom MedTacc Pte Ltd.
Zicom MedTacc Pte Ltd. Engineering & ConstructionIndustrial Services Zicom MedTacc Pte Ltd. provides engineering services. It operates as an equipment manufacturer and niche engineering service provider. The firm specializes in mechanical, hydraulics, precision, and instrumentation engineering. The company is headquartered in Singapore. | Industrial Services |
Amaranth Medical Pte Ltd. | |
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | Commercial Services |
Histoindex Pte Ltd.
Histoindex Pte Ltd. Medical SpecialtiesHealth Technology Histoindex Pte Ltd. is a medtech/healthcare company based in Singapore, Singapore. The stain-free AI platform is currently involved in multiple FDA clinical trials for nonalcoholic steatohepatitis (NASH) and has benefitted more than 150 research and academic institutes, CROs, and biopharma companies worldwide in drug discovery and development efforts for fibrotic diseases and cancers. Founded in 2010, the Singaporean company specializes in its proprietary integrated stain-free AI digital pathology platform that accurately quantifies histological features and fine measurements critical for the evaluation of therapeutic efficacy in clinical trials. The company was founded by Gideon Ho, Chi-Shang Tai, and Gideon Ho has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Thong Yuen Poon